Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Melia LA"'
Autor:
Cohen, S, Emery, P, Greenwald, M, Yin, D, Becker, J-C, Melia, LA, Li, R, Gumbiner, B, Thomas, D, Spencer-Green, G, Meng, X
Aims: Pharmacokinetic (PK) similarity was assessed among PF‐05280586 (a proposed biosimilar) vs. rituximab sourced from the European Union (rituximab‐EU) and the United States (rituximab‐US). Pharmacodynamics (PD), overall safety and immunogeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::bd842b1fdde57767510bf0108f7b39c7
https://eprints.whiterose.ac.uk/134228/1/P994.pdf
https://eprints.whiterose.ac.uk/134228/1/P994.pdf
Publikováno v:
Indonesian Journal of Chemical Research, Vol 8, Iss 1 (2020)
Fatty alcohol (FAOH) can be produced by hydrogenating of fatty acid methyl ester (FAME) using the copper-based catalyst. Copper-Chrom (Cu-Cr) is the best catalyst for high-pressure reaction condition, which is copper (Cu) as the main active component
Externí odkaz:
https://doaj.org/article/789d977bc7c6440da9692aaf7b50c7a1
Autor:
Melia Laniwati
Publikováno v:
Journal of Mathematical and Fundamental Sciences, Vol 31, Iss 2 (2019)
Sari. Isomerisasi l-buten dengan katalis zeolit alam asal Malang, Jawa Timur, dilangsungkan dalam reaktor isotermal unggun tetap dengar suhu divariasikan antara 300° dan 550°C. Reaktan berupa l-buten diproduksi melalui reaksi dehidrasi n-butanol de
Externí odkaz:
https://doaj.org/article/a35a1491f9c14f49b6c9b2e242f53a3e
Publikováno v:
ITB Journal of Engineering Science, Vol 41, Iss 1, Pp 37-49 (2009)
The synthesis of hydrogen from hydrocarbons through the steam reforming of methanol on Cu/ZnO/Al2O3 catalyst has been investigated. This process is assigned to be one of the promising alternatives for fuel cell hydrogen process source. Hydrogen synth
Externí odkaz:
https://doaj.org/article/9dd7b6b81d9a4b338c8f7f9ca8f0f4b4
Autor:
Williams JH; Pfizer Inc., San Diego, California, USA., Hutmacher MM; Ann Arbor Pharmacometrics Group, Ann Arbor, Michigan, USA., Zierhut ML; Pfizer Inc., San Diego, California, USA., Becker JC; Pfizer Inc., New York, New York, USA., Gumbiner B; Pfizer Inc., San Diego, California, USA., Spencer-Green G; Pfizer Inc., Cambridge, Massachusetts, USA., Melia LA; Pfizer Inc., San Diego, California, USA., Liao KH; Pfizer Inc., San Diego, California, USA., Suster M; Pfizer Inc., San Diego, California, USA., Yin D; Pfizer Inc., San Diego, California, USA., Li R; Pfizer Inc., Cambridge, Massachusetts, USA., Meng X; Pfizer Inc., San Diego, California, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2016 Dec; Vol. 82 (6), pp. 1568-1579. Date of Electronic Publication: 2016 Sep 22.
Autor:
Cohen S; Metroplex Clinical Research Center, Dallas, TX, USA., Emery P; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, LS7 4SA, UK.; NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Greenwald M; Desert Medical Advances, Rancho Mirage, CA, USA., Yin D; Pfizer Inc, San Diego, CA, USA., Becker JC; Pfizer Inc, New York, NY, USA., Melia LA; Pfizer Inc, San Diego, CA, USA., Li R; Pfizer Inc, Cambridge, MA, USA., Gumbiner B; Pfizer Inc, San Diego, CA, USA., Thomas D; Pfizer Inc, New York, NY, USA., Spencer-Green G; Pfizer Inc, Cambridge, MA, USA., Meng X; Pfizer Inc, San Diego, CA, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2016 Jul; Vol. 82 (1), pp. 129-38. Date of Electronic Publication: 2016 Apr 29.